Savior Lifetec Corp.
4167
Rank in Stocks
#16881
Savior Lifetec Corporation, a specialty injectable company, develops, produces,... Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Tainan City, Taiwan.
Share Price
$0.57463205
Last synced: 2026-11-10
Market Cap
$190.52M
Change (1 day)
-0.53%
Change (1 year)
1.13%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Savior Lifetec Corp. (4167)
Category
Healthcare
P/E ratio for Savior Lifetec Corp. (4167)
P/E ratio as of November 2026 TTM: 6.72
According to Savior Lifetec Corp.'s latest financial reports and stock price, its current price-to-earnings ratio (TTM) is 6.72. At the end of 2025 the company had a P/E ratio of 10.02.
P/E ratio history for Savior Lifetec Corp. from 2011 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 6.72 | -32.91% |
| 2025 | 10.02 | -71.78% |
| 2024 | 35.50 | -85.03% |
| 2023 | 237.21 | -37.80% |
| 2022 | 381.36 | -130.03% |
| 2021 | -1.27K | -3,340.16% |
| 2020 | 39.20 | -130.54% |
| 2019 | -128.34 | 1,083.46% |
| 2018 | -10.84 | -103.52% |
| 2017 | 308.25 | -1,101.05% |
| 2016 | -30.79 | 186.21% |
| 2015 | -10.76 | -31.53% |
| 2014 | -15.71 | -3.09% |
| 2013 | -16.21 | 107.47% |
| 2012 | -7.82 | -45.29% |
| 2011 | -14.28 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 32.27 | 380.01% |
US
|
|
| -27.78 | -513.31% |
US
|
|
| -26.70 | -497.11% |
AU
|
|
| 24.36 | 262.42% |
BE
|
|
| 42.44 | 531.36% |
NL
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.
Questions about Savior Lifetec Corp.'s P/E ratio
What is Savior Lifetec Corp.'s P/E ratio?
Savior Lifetec Corp.'s P/E ratio is 6.72, as of Nov 2026.
What was Savior Lifetec Corp.'s P/E ratio in 2025?
In 2025, Savior Lifetec Corp.'s P/E ratio was 10.02, compared with 35.50 in 2024.
How has Savior Lifetec Corp.'s P/E ratio changed since 2020?
From 2020 to 2025, Savior Lifetec Corp.'s P/E ratio was highest in 2022 (381.36) and lowest in 2021 (-1.27K).
How does Savior Lifetec Corp.'s P/E ratio compare with similar companies?
Savior Lifetec Corp.'s P/E ratio (6.72) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with 42.44.